Anti-Histone H2B, N-Terminal antibody produced in rabbit

Name	Anti-Histone H2B, N-Terminal antibody produced in rabbit
Supplier	Sigma-Aldrich
Catalog	SAB4503276
Prices	$335.50
Sizes	100 µg
Host	Rabbit
Clonality	Polyclonal
Applications	IHC WB
Species Reactivities	Human, Mouse
Antigen	Synthesized peptide derived from human Histone H2B
Description	Rabbit Polyclonal
Gene	HIST1H2BH
Conjugate	unconjugated
Supplier Page	Shop

Product images

<B>Immunohistochemistry</B><BR/>Histone H2B Antibody: <B>Cat. No. SAB4503276</B>: Immunohistochemistry analysis of paraffin-embedded human brain tissue, using Histone H2B Antibody. The picture on the right is treated with the synthesized peptide.

Immunohistochemistry
Histone H2B Antibody: Cat. No. SAB4503276: Immunohistochemistry analysis of paraffin-embedded human brain tissue, using Histone H2B Antibody. The picture on the right is treated with the synthesized peptide.

<B>Immunofluorescence</B><BR/>Anti-Histone H2B: <B>Cat. No. SAB4503276</B>: Immunofluorescence of HeLa cells using Anti-Histone H2B antibody. Cells on the left were treated with the Anti-Histone H2B antibody. Cells on the right (negative control) were treated with both Anti-Histone H2B antibody and the synthesized immunogen peptide.

Immunofluorescence
Anti-Histone H2B: Cat. No. SAB4503276: Immunofluorescence of HeLa cells using Anti-Histone H2B antibody. Cells on the left were treated with the Anti-Histone H2B antibody. Cells on the right (negative control) were treated with both Anti-Histone H2B antibody and the synthesized immunogen peptide.

<B>Immunoblotting</B><BR/>Anti-Histone H2B: <B>Cat. No. SAB4503276</B>: Immunoblotting analysis of extracts from A549 cells, using Anti-Histone H2B antibody. The lane on the left was treated with the Anti-Histone H2B antibody. The lane on the right (negative control) was treated with both Anti-Histone H2B antibody and the synthesized immunogen peptide.

Immunoblotting
Anti-Histone H2B: Cat. No. SAB4503276: Immunoblotting analysis of extracts from A549 cells, using Anti-Histone H2B antibody. The lane on the left was treated with the Anti-Histone H2B antibody. The lane on the right (negative control) was treated with both Anti-Histone H2B antibody and the synthesized immunogen peptide.